UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Nature cell biology, ISSN 1465-7392, 07/2017, Volume 19, Issue 8, pp. 1003 - 1003
Journal Article
Journal of cell science, ISSN 0021-9533, 07/2018, Volume 131, Issue 14, pp. e1404 - e1404
Journal Article
Nature (London), ISSN 0028-0836, 02/2016, Volume 530, Issue 7589, pp. 233 - 236
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Plasmodium falciparum - enzymology | Plasmodium - enzymology | Plasmodium chabaudi - enzymology | Species Specificity | Humans | Proteasome Inhibitors - chemistry | Plasmodium - drug effects | Plasmodium falciparum - drug effects | Protein Subunits - metabolism | Dose-Response Relationship, Drug | Artemisinins - pharmacology | Plasmodium chabaudi - physiology | Drug Design | Plasmodium - growth & development | Female | Drug Resistance | Antimalarials - adverse effects | Catalytic Domain | Proteasome Inhibitors - pharmacology | Models, Molecular | Proteasome Endopeptidase Complex - chemistry | Proteasome Inhibitors - toxicity | Proteasome Inhibitors - adverse effects | Antimalarials - pharmacology | Cryoelectron Microscopy | Drug Synergism | Animals | Substrate Specificity - drug effects | Proteasome Endopeptidase Complex - ultrastructure | Antimalarials - chemistry | Plasmodium chabaudi - drug effects | Mice | Mice, Inbred BALB C | Protein Subunits - antagonists & inhibitors | Protein Subunits - chemistry | Antimalarials - toxicity | Enzyme Activation | Plasmodium falciparum - growth & development | Proteasome Endopeptidase Complex - metabolism | Ubiquitin-proteasome system | Plasmodium | Health aspects | Proteins | Malaria | Protease inhibitors | Proteases | Erythrocytes | Ligands | Parasites | Drug dosages | Index Medicus
Journal Article
Cancer and metastasis reviews, ISSN 0167-7659, 12/2017, Volume 36, Issue 4, pp. 561 - 584
Biomedicine, general | Biomedicine | Proteasome inhibitor | Multiple myeloma | Tumor progression | Cancer Research | Oncology | 20S proteasome | Ubiquitin-proteasome system | Life Sciences & Biomedicine | Science & Technology | Multiple Myeloma - drug therapy | Proteasome Inhibitors - pharmacology | Humans | Proteasome Inhibitors - administration & dosage | Drug Resistance, Neoplasm | Proteasome Endopeptidase Complex - metabolism | Multiple Myeloma - enzymology | Randomized Controlled Trials as Topic | Ubiquitin | Chemotherapy | Biological products | Monoclonal antibodies | Development and progression | Drug approval | Cancer | Drugs | NF-κB protein | Histone deacetylase | Bortezomib | Immunomodulation | Pathogenesis | Downstream effects | Growth factor receptors | FDA approval | Proteasome inhibitors | Proteins | Angiogenesis | Signaling | Receptors | Biological effects | Inhibitors | Protease inhibitors | Protein folding | Reagents | Inhibition | Endoplasmic reticulum | Index Medicus
Journal Article
Scientific reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 17626 - 12
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Lung Neoplasms - drug therapy | Epithelium - pathology | Proteasome Inhibitors - pharmacology | Apoptosis - drug effects | Humans | Cell Line, Tumor | Antineoplastic Agents - pharmacology | Bortezomib - pharmacology | Mesothelioma, Malignant | Proteasome Endopeptidase Complex - metabolism | Ubiquitinated Proteins - metabolism | Mesothelioma - drug therapy | Ubiquitin | Mesothelium | Asbestos | Bortezomib | Toxicity | Clinical trials | Proteasomes | Mesothelioma | Proteasome inhibitors | Apoptosis | Cancer | Index Medicus
Journal Article
Cancer and metastasis reviews, ISSN 0167-7659, 12/2017, Volume 36, Issue 4, pp. 599 - 615
Biomedicine, general | Constitutive proteasome | Biomedicine | Leukemia | Proteasome inhibition | Cancer Research | Oncology | Drug resistance | Immunoproteasome | Life Sciences & Biomedicine | Science & Technology | Acute Disease | Proteasome Inhibitors - pharmacology | Humans | Leukemia - enzymology | Proteasome Inhibitors - administration & dosage | Leukemia - drug therapy | Drug Resistance, Neoplasm | Bortezomib - pharmacology | Molecular Targeted Therapy | Proteasome Endopeptidase Complex - genetics | Animals | Bortezomib - administration & dosage | Leukemia - immunology | Cell Line, Tumor | Proteasome Endopeptidase Complex - metabolism | Proteasome Endopeptidase Complex - immunology | Leukemia - genetics | Acute leukemia | Health aspects | Analysis | Cell culture | Inhibitors | Bortezomib | Protease inhibitors | Therapeutic applications | Proteolysis | Multiple myeloma | Proteasomes | Mutation | Proteasome inhibitors | Index Medicus
Journal Article
Journal of molecular biology, ISSN 0022-2836, 11/2017, Volume 429, Issue 22, pp. 3500 - 3524
ubiquitin proteasome system | proteasome | proteasome assembly | protein degradation | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Cryoelectron Microscopy | Eukaryotic Cells - enzymology | Proteasome Endopeptidase Complex - metabolism | Proteasome Endopeptidase Complex - ultrastructure | Protein Multimerization | Ubiquitin | Proteolysis | Phosphatases | Index Medicus
Journal Article